• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA SP WITH MAXZERO; PERIPHERAL IV CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA SP WITH MAXZERO; PERIPHERAL IV CATHETERS Back to Search Results
Catalog Number 383551
Medical Device Problem Code Material Puncture/Hole (1504)
Health Effect - Clinical Code Pain (1994)
Date of Event 11/15/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Investigation results: the complaint that the needle had gone through the iv catheter tubing was confirmed and the cause appeared to be associated with use.One 24g nexiva device from lot 4215289 was provided for investigation.The needle was protruding through the side of the catheter tubing.The section of tubing between the puncture site and the catheter tip contained what appeared to be blood residue, which indicates that the needle and iv catheter tubing likely accessed the vessel.The instructions for use (ifu) state, "if the needle is partially or completely withdrawn from the catheter tubing during insertion, do not re-insert the needle into the catheter tubing as damage may occur." no defects associated with the manufacturing process were identified on the returned sample.Manufacturing controls are in place to mitigate the occurrence of this type of failure.A review of manufacturing records did not find any issue related to the failure during the production of this batch.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.
 
Event or Problem Description
No additional information.
 
Event or Problem Description
It was reported that bd.The following information was provided by the initial reporter: rn went to start the patient iv for treatment.Rn inserted the angiocath and when she went to withdraw the needle from the angiocath.Patient complained of pain and when nurse pulled the iv she found that the needle had gone through the plastic sheath, angiocath was a 24 gauge x 0.75 in bd nexiva.Lot number was 4215289.This is the second incidence of this, this week by 2 different rn's.(b)(6).Please provide the date of event.11/15/24.
 
Additional Manufacturer Narrative
H.3.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.E1.Street address information was not provided, therefore, was used as a place holder.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA SP WITH MAXZERO
Common Device Name
PERIPHERAL IV CATHETERS
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key20854775
Report Number1710034-2024-01434
Device Sequence Number8905213
Product Code FOZ
UDI-Device Identifier00382903835515
UDI-Public(01)00382903835515(11)240802(17)270731(10)4215289
Combination Product (Y/N)N
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
K183399
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Administrator/Supervisor
Type of Report Initial,Followup
Report Date (Section B) 01/08/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number383551
Device Lot Number4215289
Was Device Available for Evaluation? Device Returned to Manufacturer
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/14/2024
Supplement Date Received by Manufacturer01/08/2025
Initial Report FDA Received Date12/05/2024
Supplement Report FDA Received Date01/09/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/02/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-